🔎 Trials Near Me

መነሻ › የጡንቻ ካንሰር › Washington › Tacoma

በTacoma፣ WA ለየጡንቻ ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች

ለየጡንቻ ካንሰር የሚደረጉ 18 ጥናቶች በTacoma እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

The Vanguard Study: Testing a New Way to Screen for Cancer

ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
  • Madigan Army Medical Center, Tacoma
እድሜ ከ45 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT06995898

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Northwest Medical Specialties, Tacoma
  • Providence Regional Cancer System, Lacey · 23 ማይል ርቀት
እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05827081

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
  • Providence Regional Cancer System-Lacey, Lacey · 23 ማይል ርቀት
እድሜ ከ40 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05334069

A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, Puyallup · 8 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT07205822

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Northwest Medical Specialties, Puyallup · 8 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT07102381

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Northwest Medical Specialties, PLLC ( Site 0062), Tacoma
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT07060807

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, Tacoma
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06103864

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Northwest Medical Specialties, Tacoma
  • Northwest Medical Specialties, Gig Harbor · 8 ማይል ርቀት
  • Northwest Medical Specialties, Puyallup · 8 ማይል ርቀት
  • እና 1 ተጨማሪ
እድሜ 60 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06377852

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Northwest Medical Specialties, PLLC ( Site 0067), Tacoma
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06966700

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

ተሳታዮችን በመፈለግ ላይ
  • MultiCare Cancer Institute, Tacoma
  • Northwest Medical Specialties, PLLC, Puyallup · 8 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT07214532

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Clinical Trial Site, Olympia · 26 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT07085767

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • MultiCare Health System, Tacoma
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07174336

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Northwest Medical Specialties, PLLC, Tacoma
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT07173751

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • MultiCare Cancer Institute - Tacoma, Tacoma
  • Northwest Medical Specialties PLLC, Tacoma
  • Vista Oncology, Olympia · 26 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT06492616

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Northwest Medical Specialties, Tacoma
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06790693

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Providence Regional Cancer System-Lacey, Lacey · 23 ማይል ርቀት
እድሜ ከ18 እስከ 60 · ሴቶች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT05879926

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Northwest Medical Specialties, PLLC, Tacoma
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኤፕሪ 2026 · NCT05735080

BostonGene and Exigent Genomic INsight Study

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Northwest Medical Specialities, Puyallup · 8 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ፌብሩ 2025 · NCT06272864

በሌሎች ከተሞች ለየጡንቻ ካንሰር የሚደረጉ ጥናቶች

በTacoma ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።